Walleye Capital’s Pediatrix Medical MD Stock Holding History

Walleye Capital’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-30,900	Closed	-$699K	–	2067
2019 Q3	$699K	Buy	30,900 +13,100	+74%	+$299K	0.04%	589
2019 Q2	$449K	Buy	+17,800	New	+$478K	0.05%	540

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Walleye Capital's MD Position: Q3 2024 in Review

Walleye Capital sold out of Pediatrix Medical (MD) in Q3 2024, closing a stake of 167,587 shares — an estimated $1.27M sold.

Walleye Capital first reported a position in MD in Q1 2023 and held it in 3 quarters. The position peaked at $1.27M in Q2 2024. 218 funds tracked by Wall St. Rank hold MD as of Q3 2024.

Walleye Capital reported no remaining Pediatrix Medical position as of Q3 2024 after selling out during the quarter.
Walleye Capital sold 167,587 Pediatrix Medical shares in Q3 2024, an estimated $1.27M.
Walleye Capital first reported a position in Pediatrix Medical in Q1 2023 and held it in 3 quarters.
Walleye Capital's Pediatrix Medical position peaked at $1.27M in Q2 2024.
218 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2024.

Based on Walleye Capital's 13F filing for Q3 2024, filed 14 Nov 2024.